The esters of erythromycin. 1979

P G Welling

UI MeSH Term Description Entries
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P G Welling
May 1973, Clinical chemistry,
P G Welling
September 1957, Antibiotics & chemotherapy (Northfield, Ill.),
P G Welling
June 1988, The Journal of antimicrobial chemotherapy,
P G Welling
June 1976, Journal of chromatography,
P G Welling
August 1969, Applied microbiology,
P G Welling
November 1959, Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
P G Welling
April 1972, Journal of chromatography,
P G Welling
January 1988, The Journal of antibiotics,
Copied contents to your clipboard!